| Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived154 of 154show fewer |
|---|
| → investigated in trials for | Brentuximab Vedotinadc 91 trials (27 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 91 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall_molecule 87 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 81 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 81 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 56 trials (22 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 55 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 54 trials (28 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 49 trials (21 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall_molecule 48 trials (23 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall_molecule 42 trials (17 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 39 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 34 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 30 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 25 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 24 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 20 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 19 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall_molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall_molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall_molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bone Marrow Transplantation 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Conatumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibuprofensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Meloxicamsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niacinamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triptorelinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |